Horizon scanning: Randomised, sham-controlled study of aflibercept (VEGF Trap Eye) for macular oedema in CRVO

Source: Ophthalmology
Area: News
Six-month results from the COPERNICUS study evaluating intravitreal aflibercept ophthalmic solution (VEGF Trap-Eye) in the treatment of macular oedema secondary to central retinal vein occlusion (CRVO) have now been fully published.  These results were previously reported at conference at the end of 2010 (see related NeLM report at the link below).      COPERNICUS is an ongoing, 2-year double-blind RCT study being conducted at 70 sites in the United States, Canada, India, Israel, Argentina, and Colombia.  Participants have macular oedema secondary to CRVO diagnosed within 9 months (Read more...)

Full Story →